Drug intelligence / Profile preview

sulfaguanidine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Sulfaguanidine is a sulfonamide antibiotic and a guanidine derivative of sulfanilamide, primarily used in veterinary medicine and formerly in human medicine for the treatment of gastrointestinal bacterial infections such as bacillary dysentery. It is characterized by poor absorption from the gut, which allows it to act locally within the intestinal tract. The drug exerts its antibacterial effect by inhibiting dihydropteroate synthase, thereby blocking the synthesis of dihydrofolic acid from para-aminobenzoic acid (PABA) in bacteria. This mechanism disrupts folic acid synthesis, leading to bacteriostatic activity against susceptible organisms[1][4][8]. Sulfaguanidine was introduced in 1940 and has been widely used for enteric infections due to its minimal systemic absorption[1].

Brand names
RuocidSulginum
Other names
sulfaguanidinesulphaguanidinesulfaguanidinsulfanilguanidinguanicilsulfaguanidinumsulfaguanidina
02

Targets

DHPS (Dihydropteroate synthase)

Beyond the preview

Go deeper on sulfaguanidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sulfaguanidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call